Drug stocks dip; Orexigen rallies on drug update – MarketWatch
By Dr. Matthew Watson
 TopNews United Kingdom (blog) | Drug stocks dip; Orexigen rallies on drug update MarketWatch The NYSE Arca Pharmaceutical Index (NYSE:DRG) and the NYSE Arca Biotechnology Index (NYSE:BTK) both moved marginally lower to 278.86 and 1074.31, ... Orexigen, Amylin gain on diabetes studiesMarketWatch |
Uncategorized
Comments Off on Drug stocks dip; Orexigen rallies on drug update – MarketWatch |
June 29th, 2010
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research